Novacyt: shares take a beating
AIM’s top performer in 2020 has fallen back to earth after a disappointing trading update. Are the shares now a bargain or is there more trouble ahead? We offer our thoughts on this amazing little business.
The share price of Novacyt (LON: NCYT), the clinical diagnostics specialist and AIM’s top performer in 2020, tumbled 40% today on news that it is dispute with Department of Health and Social Care (DHSC).
Background
Previous article Next article